2017
Noncoding RNAs in Cholesterol Metabolism and Atherosclerosis
Price N, Fernández-Hernando C. Noncoding RNAs in Cholesterol Metabolism and Atherosclerosis. Cardiac And Vascular Biology 2017, 2: 21-37. DOI: 10.1007/978-3-319-52945-5_2.Peer-Reviewed Original ResearchLow-density lipoprotein cholesterolPlasma LDL-C levelsDysregulation of cholesterolLDL-C levelsPrimary risk factorTreatment of atherosclerosisLipoprotein cholesterolCardiometabolic diseasesCholesterol levelsRisk factorsEffective therapyCholesterol metabolismAtherosclerosisHuman morbidityProper metabolic functionProminent causeElevated levelsLipid homeostasisGenetic factorsDiseaseCholesterolMetabolic functionsMorbidityLevelsPosttranscriptional level
2010
microRNAs, Plasma Lipids, and Cardiovascular Disease
Dávalos A, Fernández-Hernando C. microRNAs, Plasma Lipids, and Cardiovascular Disease. Current Cardiovascular Risk Reports 2010, 5: 10-17. DOI: 10.1007/s12170-010-0145-1.Peer-Reviewed Original ResearchCardiovascular diseaseShort non-coding RNAsPost-transcriptional repressionHigh-density lipoprotein biogenesisMiR-33Non-coding RNAsTotal cholesterol levelsCassette transporter A1Expression of ATPMiR-122 expressionAberrant regulationGene expressionLipoprotein biogenesisDyslipidemic patientsLipid homeostasisMetabolic syndromePlasma lipidsCholesterol levelsLeading causeLipoprotein metabolismABCG1 transportersCholesterol effluxCholesterol metabolismPathologic processesMultifactorial disorder